Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 24964-64-5 | MDL No. : | MFCD00003344 |
Formula : | C8H5NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HGZJJKZPPMFIBU-UHFFFAOYSA-N |
M.W : | 131.13 | Pubchem ID : | 90670 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 36.54 |
TPSA : | 40.86 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.26 cm/s |
Log Po/w (iLOGP) : | 1.25 |
Log Po/w (XLOGP3) : | 1.18 |
Log Po/w (WLOGP) : | 1.37 |
Log Po/w (MLOGP) : | 0.77 |
Log Po/w (SILICOS-IT) : | 1.96 |
Consensus Log Po/w : | 1.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.77 |
Solubility : | 2.2 mg/ml ; 0.0168 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.63 |
Solubility : | 3.05 mg/ml ; 0.0232 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.4 |
Solubility : | 0.528 mg/ml ; 0.00403 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.29 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With potassium carbonate In water at 20℃; for 5 h; | General procedure: A mixture of bromine chloride resin and K2CO3 in MeOH–H2O (8:2) 3 mL was placed in a round-bottom flask fitted with amagnetic stirrer. To this, the aldehyde (1 mmol, 1 equiv) was added dropwise, and the reaction mixture stirred at r.t. The progress of the reaction was monitored by TLC. After completionof the reaction the mixture was filtered, and the filtrate was extracted with Et2O. The ether layer was washed with H2O, brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column chromatography, if required, over silicagel (60–120 mesh) using a mixture of PE and EtOAc (9:1) as eluent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With lithium aluminium tetrahydride In tetrahydrofuranHeating / reflux | Lithium aluminum hydride (1.0 M in THF, 29.9 mL, 29.9 mmol) was added slowly to a solution of 3-cyanobenzaldehyde (1.12 g, 9.25 mmol) in anhydrous THF (25.0 mL) at room temperature under argon and the mixture was stirred at reflux (overnight). The reaction mixture was cooled to room temperature and quenched by addition of ice and NaOH (aq. 3.0 N, 10.0 mL). The mixture was extracted with chloroform (3 x 80 mL) and the combined organic phase was washed with brine (2 x 20 mL) and dried (Na2SO4). The solvent was evaporated and the residue was purified by silica gel column chromatography to yield [3- (hydroxymethyl)phenyl] amine as colorless oil (70percent yield). [1H NMR (CDCl3): δ 7.26-7.22 (m, IH), 7.21-7.19 (m, IH), 7.16-7.14 (m, IH), 7.12-7.09 (m, IH), 4.55 (d, 2H, J = 6.0 Hz), 3.71 (d, 2H, /= 8.0 Hz); 13C NMR (CDCl3): δ 142.7, 142.0, 128.6, 126.0, 125.5, 125.4, 64.4, 46.1; FAB-MS m/z 138.1 (MH+).] Reaction of this material according to general procedure G provided 23f in 38percent yield. 1H NMR (CDCl3): δ 7.22 (s, IH), 7.20-7.18 (m, 2H), 7.11-7.09 (m, IH), 6. 98 (d, IH, 7 = 8.4 Hz), 6.91 (d, IH, 7 = 8.4 Hz), 4.60 (s, 2H), 4.57 (s, 2H), 4.06 (s, 2H), 4.01 (d, 3H, 7 = 1.2 Hz), 3.80 (d, 3H, 7 = 1.2 Hz); 13C NMR (CDCl3): δ 166.8, 152.2, 147.2, 141.9, 137.1, 134.5, 128.8, 127.0, 126.6, 126.1, 124.7, 117.8, 116.5, 64.6, 62.4, 56.7, 48.5, 46.2; FAB-MS m/z 314.1 (MH+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | Stage #1: at 100℃; for 4 h; Stage #2: With hydrogenchloride In water at 20℃; |
General procedure: 3-Cyanobenzaldehyde (11a) or 4-cyanobenzaldehyde (11b) (15 mmol) and malonic acid (30 mmol) were dissolved in pyridine (30 mL). Piperidine (3.0 mmol) was added and the reaction was heated for 4 h at 100 °C. The reaction was cooled to room temperature and 5 M HCl (25 mL) was added slowly. The resulting white precipitate was collected by filtration, washed with water and dried to give (E)-3-cyanocinnamic acid (12a) or (E)-4-cyanocinnamic acid (12b) in yields of 81percent and 78percent, respectively. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | Stage #1: With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 20℃; Stage #2: With sodium carbonate In dichloromethane; water |
Preparation 14: 1-[3-(4-WlethyI-piperazin-1-ylmethyl)-phenyI]-ethanone; STEP A; A mixture of 3-formyl-benzonitrile (1.5 g, 11.45 mmol), N-methyl piperazine (1.49 g, 14.9 mmol) and NaBH(OAc)3 (3.63 g, 17.18 mmol) in DCM (75 ml) and CH3COOH (0.851 ml, 14.9 mmol) was stirred overnight at room temperature, then diluted with DCM and washed with 1 M Na2CO3. The organic phase was dried over Na2SO4 and evaporated in vacuo. The crude mixture was purified by column chromatography (eluent: DCM/MeOH/NH4OH 97:3:0.5) to give 1.7 g of 3-(4- methyl-piperazin-1-ylmethyl)-benzonitrile. Y= 70percent |
70% | Stage #1: With sodium tris(acetoxy)borohydride; acetic acid In dichloromethane at 20℃; Stage #2: With sodium carbonate In dichloromethane; water |
STEP A A mixture of 3-formyl-benzonitrile (1.5 g, 11.45 mmol), N-methyl piperazine (1.49 g, 14.9 mmol) and NaBH(OAc)3 (3.63 g, 17.18 mmol) in DCM (75 ml) and AcOH (0.851 ml, 14.9 mmol) was stirred at RT overnight and then diluted with DCM and washed with 1 M Na2CO3. The organic phase was dried over Na2SO4 and evaporated under vacuum. The crude product was purified by column chromatography (eluent: DCM/MeOH/NH4OH 97:3:0.5) to give 3-(4-methyl-piperazin-1-yl-methyl)-benzonitrile (1.7 g). Y=70percent |